FOR centuries, gout has been a deeply misunderstood disease, associated only with jolly, indulgent, and often big men. When Henry VIII was diagnosed, it became firmly entrenched in popular belief ...

The current strategy for managing chronic gout is the use of uric-acid-lowering drugs to reduce urate production or of a uricosuric agent to promote renal uric acid excretion. Probenecid is ...

Uric acid crystals can accumulate under the skin and form lumps called "tophi." Chronic (long-term) gout can cause knee ...

The refractory gout market is growing because of the rising prevalence of gout brought on by aging populations and changes in ...

A recent study published in Diabetes, Obesity and Metabolism has revealed the detrimental interplay between gout and chronic ...

The food you consume directly impacts your body, influencing energy levels, inflammation, blood sugar, and joint health.

Sweden’s Sobi has kicked off a rolling biologics license application in the US for SEL-212, vying to become a new option for patients with refractory chronic gout that doesn’t respond to ...

Urate-lowering therapies benefited patients with gout and stage 3 chronic kidney disease without raising the risk of kidney ...

A recent study highlights a surprising issue for people living with gout in the United States: most gout flares are never ...

Febuxostat is a second-line option for patients with gout who are unable to take allopurinol due to hypersensitivity, intolerance, or lack of efficacy in achieving a target serum uric acid ...